HCPCS J3375 is officially defined as "Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg." HCPCS J3375 is referenced in 2 tracked payer policy changes from Michigan Medicaid - MDHHS and Blue Cross Blue Shield of Rhode Island. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J3375 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.